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Abstract: Six N-heterocyclic Carbene based Ionic Liquids (ILs) have been synthesized by conventional methods. The ILs were spectroscopically 
characterized by NMR and FT-IR techniques. Their in vitro antimicrobial activities were determined towards gram-positive and gram-negative 
bacterias and yeast strains using minimum inhibition concentration (MIC) assay. The best inhibition performances were obtained with 
compound 1 due to its more hydrophilic nature compared with the others. It exhibited 1 mg L–1 MIC value against to the most bacteria while 
the others showed 4 mg L–1. 
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INTRODUCTION 
he term “Green chemistry” has been accepted as the 
movement towards environmental friendly chemical 
processes and products for a recent decade. Researchers in 
all over the world have attempted considerable efforts to 
explore novel, environmental-friendly chemicals or materi-
als that they should contribute green chemistry or sustain-
able chemistry concepts.  For achieving this aim, ionic 
liquids (ILs) are a very best class of novel materials. Ionic 
liquids are known as a class of compounds, composed of an 
anion and cation like salts. Their melting point are below 
100 °C. ILs have attracted an increasing attention for their 
unique physical and chemical properties such as low vapor 
pressure, high polarities, electrical conductivities and non-
flammability.[1–3] Since they have multi-faced capabilities, 
every researcher has handled them from different aspects. 
In a study polymer material exhibited good solubility in 
Ils,[4] while in some other studies the researchers tested ILs 
for their gas solubility.[5] Therefore, they seem to be 
substituted for volatile organic compounds (VOCs) as 
different solvents. Besides, ILs and NHCs are used as 
regenerable reaction media and catalysts as metal-free 
salts and metal complexes.[6–9] Also, some researchers have 
investigated them for their use in electrochemical 
applications too.[10–12] Recent days they have been 
subjected to physical explorations because of their liquid 
phase properties such as liquid-liquid equilibrium and 
solubilities in other liquids,[13–15] and tested NHC derivative 
ILs in supported membrane studies, extraction[16,17] and in 
nanochemistry too.[18,19] 
 N-heterocyclic carbenes (NHCs) are cyclic compounds 
containing one or mostly two N atoms in the main C ring 
(Figure 1). Many natural compounds such as caffeine and 
some amino acids like uraconic acid contain an N-
heterocyclic part, and NHC salts can be obtained by simple 
modifications of these natural compounds. (Figure 2).[20–22] 
 NHCs are mostly used as ligands for complexation 
reactions with transition metals like Ag(I), Pd(II), Pt(II), etc. 
The transition metal complexes of NHCs have been studied 
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and used as catalysts in various types of reactions such as 
polymerization, cyclization, reduction/oxidation, C–C bond 
formation/cleavage, hydrosilylation, etc.[23] Also, some re-
searches have been conducted to utilize them as antimicro-
bial agents,[24] as a surface antigen against hepatitis B[25] 
and even as anticancer drug candidates.[26] The Antimicro-
bial activities of Ag(I)-NHC complexes have been examined 
by Young et. al. since 2004 to present day.[27–30] Roland et. 
al. also examined a series of Ag(I) NHC complexes for their 
antimicrobial properties as well.[31] Metal-free NHC com-
pounds and their derivatives were also examined for their 
biological and medicinal activities by many researchers.[32,33] 
Antimicrobial activities and other pharmaceutical proper-
ties such as toxicity and antiseptic activities of ILs were 
pioneered by the research groups of Iawa and Gonzalez-
Chavez rigorously.[34,35] According to their studies, the pri-
mary advantage of the ILs in use is their well adjustable 
electronic, steric and other properties with changing the 
substituents and counter anions. 
 In this study, we have synthesized six novel ILs (com-
pounds 1–6) and examined them for their antimicrobial 
activity. 
 
MATERIALS AND METHODS 
 
Synthesis and Characterization of 
N-Heterocyclic Carbene Salts  
Six novel N-heterocyclic carbenes (as of now referred as 1–
6) were synthesized by conventional methods described in 
R&D. All materials and solvents such as imidazole, N-methyl 
imidazole, 2-bromoethaneamine hydrobromide were ob-
tained from Sigma-Aldrich, Merck, and Alfa-Aesar and used 
without further purification. All synthesizing process were 
carried out in schlenk type tubes. Reaction progress was 
monitored by TLC (thin layer chromatography) using alumi-
num sheets coated with silica gel. Melting points were 
taken on a Yanagimito micro-melting point apparatus and 
uncorrected. IR spectra were measured on a Perkin Elmer 
Spectrum100 FT-IR spectrometer. 1H and 13C NMR spectra 
were taken on spectrometer at VARIAN Infinity Plus 300 
and 75 Hz respectively. 1H and 13C shifts were referenced to 
the internal deuterated solvent. The second peak in the 
acidic region referred that the “-.HBr” group has not left the 
molecule during the synthesis process. 
  
Antimicrobial Activity 
In vitro antimicrobial activity of the compounds (1–6) were 
investigated against microorganisms including three Gram-
positive bacteria (Staphylococcus aureus ATCC6538, 
vancomycin resistant Enterococcus faecium (VREF) DSM 
13590, Bacillus subtilis ATCC 168, three Gram-negative 
bacteria (Escherichia coli O157:H7 RSKK 234, Salmonella 
typhimurium CCM 5445, Pseudomonas aeruginosa ATCC 
27853) and three yeast strains (Candida albicans ATCC 
10231, Candida krusei ATCC 6258 and Candida tropicalis 
RSKK 665). The biological methods for cultivation of 
bacterial strains and determination of antimicrobial activity 
have been carried out according to CLSI[36] and explained in 
following lines. 
 Bacterial strains were cultivated on Mueller-Hinton 
agar (MHA) and yeasts were grown on Sabouraud Dextrose 
Agar (SDA). The suspension of the test microorganisms was 
adjusted according to 0.5 cfu mL–1 McFarland turbidimetric 
standards. The antimicrobial activity of each compound 
was evaluated by determination of the minimum inhibition 
concentration (MIC), defined as the lowest concentration 
of antimicrobial agent that inhibits growth after incubation. 
The assay was performed on the tested microorganisms by 
microdilution method according to Clinical and Laboratory 
Standards (CLSI).[36] To prepare dilution series in the 
concentration range of 0.004–4 mg mL–1, 20 µL of all 
dilutions were transferred to the wells filled with MHB 
medium (180 μL final volume). Microorganism suspension 
(20 µL) was then added to the wells. MHB medium without 
compound served as control. Gentamicin sulfate was used 
as reference antibiotic for bacteria and nystatin for yeasts. 
The cultures were incubated at 37 °C for 24 h. The growth 
of the microorganism was determined visually; the first 
well observed no visible growth was determined as the 
MIC. All experiments were performed in triplicate. 
 
Figure 1. Examples for the types of ILs with N atoms. 
 
Figure 2. Examples for NHC compounds originated from 
natural compounds. 
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RESULTS AND DISCUSSION 
 
Chemical Structures of ILs 
The synthesize reactions of the ILs tested in this study are 
shown together in the Scheme 3. Six ILs (NHC salts) were 
prepared and structurally characterized with –NH2·HBr 
groups and with Br– counter anion. The product yields 
ranged from 68 to 92 as shown in Table 1 which also 
includes 1H NMR, 13C NMR, and FT-IR spectroscopic data. 
 A representative FT-IR spectrum, 1H NMR and  
13C NMR spectra of compound 1 are shown in Figures 3a, 
3b and 4, respectively. The FT-IR spectra of these 
compounds confirm the presence of the –NH2.HBr groups 
from the broad peak in 2400–3500 cm–1. The peaks at 
~2970s cm–1 and 2930s cm–1 correspond to methyl and 
 
 
Scheme 1. One step DMF method for synthesizing 
symmetrical NHC salts. 
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Scheme 2. Sequential method for synthesizing dis-
symmetrical NHC salts. 
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Scheme 3. Synthesize routes for the ILs concerned in this 
study: i: N-methylimidazole, toluene, 2–3 h, 50–60 °C;  
ii: imidazole or benzimidazole, DMF, 10–12 h,50–60 °C;  
iii: 1-(2-methoxyethyl)-1H-imidazole/benzimidazole, 2–3 h, 
50–60 °C; iv: 2-((1H-imidazol-1-yl)methyl)-4,6-di-tert-
butylphenol, 3 h, 50–60 °C). 
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Figure 3. 1H (a) and 13C (b) NMR spectrum of IL 1. 
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methylene C–H bonds. The Amine, methyl and aromatic 
groups in the structures are consistent with the FT-IR 
spectra. Also, in the 1H NMR spectra the two peaks in the 
acidic region show that -H.Br groups in the compounds 
have not left the structure during the synthesize reactions. 
The experimental NMR and FT-IR spectra are in good 
agreement with the expected values and the structures of 
the synthesized NHC salts. 
Synthesis of Dis-Symmetric Compounds 
1,4,5,6 
To a solution of corresponding mono substituted imid-
azolium/benzimidazolium mid-product in toluene which 
contains 0.01 mol of mid-product, 1 eq. (2.05 g or 0.01 mol) 
of 2-bromoethaneamine hydrobromide was added. The 
reaction mixture was heated 50-60°C with stirring for 2 or  
3 hours. After cooling to room temperature, the solvent was 
distilled out under vacuum in a gas-vacuum manifold system. 
The reaction residue was washed with 5 mL of hexane three 
times and dried in vacuum, resolved in a minimum amount 
of CH2Cl2. The partially purified residue was washed with 
hexane again and hexane phase was removed by 
decantation. The residue was dried in a vacuum desiccator. 
 
Table 1. Physical properties of the ILs 1–6. 
Compounds 
Chemical and Physical Properties 
Mw 
1H NMR Shifts 13C NMR Shifts 
Solubility 
in water 
Physical 
situation 
or melting 
point  
Selected 
FT-IR 
Values / 
cm–1 
TLC Rf 
(acetone : 
THF 1: 1) Formulae C2 Back1 Back2 Tale C2 Back1 Back2 Tale 
1 
   
287 9.173 7.724 8.254 4.496 179.312 123.080 124.459 40.096 Good Liq. 
3400.18, 
2951.94, 
1579.59, 
1172.41 
0.28 
2 
 
417 9.076 7.800 7.593 3.607 179.082 119.826 134.675 39.832 Good Liq. 
3423.04, 
2934.85, 
1640, 
1387.94, 
1099.21 
  
0.6 
3 
 
467 9.659 7.748 7.484 3.637 179.717 127.729 130.840 39.961 Good Liq. 
3312.10, 
2763.85, 
1650.84, 
1386.94, 
1097.69 
 
0.55 
4 
 
331 9.208 7.772 7.662 3.652 179.364 120.502 124.297 40.312 Good Liq. 
3349.29, 
2942.18, 
1655.42, 
1388.73, 
113.71 
 
0.44 
5 
 
381 9.823 8.257 8.727 3.739 180.126 114.315 116.034 40.677 Good 43–45 °C  
3463.33, 
3021.00, 
1561.18, 
1117.11 
0.33 
6 
 
491 9.138 7.710 7.966 4.873 179.560 120.031 136.232 40.127 
Less than 
others 
67–69 °C 
3490, 
2952.54, 
2868.03, 
1575.33, 
1361.38, 
1003 
.078 
 
Figure 4. FT-IR spectrum of IL 1. 
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Synthesis of Symmetric Compounds 2,3 
To a solution of imidazole/benzimidazole in DMF, which 
contains 0.01 mol of starting material, 2 eq. (4.1 g or  
0.02 mol) of 2-bromoethaneamine hydrobromide was 
added after stirring for 20–30 min. The reaction mixture 
was heated 50–60 °C with stirring for 10 or 12 hours. After 
cooling them to room temperature, the products (com-
pounds 2 and 3) were exposed to the same purification 
procedure with dis-symmetric compounds. 
Antimicrobial Activities of ILs 
In vitro antimicrobial activity of the compounds (1–6) were 
tested against microorganisms including three gram-posi-
tive, three gram-negative bacteria and three yeast strains 
The biological methods for cultivation of bacterial strains 
and determination of antimicrobial activity have been 
carried out according to CLSI.[34] The growth of the 
microorganism was determined visually; the first well 
observed no visible growth was determined as the MIC. All 
experiments were performed in triplicate. All results have 
been given in Table 2. 
 
CONCLUSIONS 
The antimicrobial activities of six imidazolium derivative 
compounds were determined on six different bacterias and 
three yeasts. MIC values determined for ILs are given in 
Table 1. We observed that approximately all of compounds 
have a small antimicrobial activity against gram-negative 
bacteria, whereas, MIC values of all samples against  
S. aureus (4 mg L–1) were promising. All of the compounds 
were shown better antimicrobial activity against the yeasts 
compared to the bacterial strains. Among them compound 1 
showed a significant antimicrobial activity against to both 
bacterias and yeasts compared to other compounds (2–6). 
Also, compound 3 was effective towards only gram-negative 
bacteria, P. aeruginosa and yeast C. tropicalis in relatively 
lower concentrations. Compound 6 exhibited considerable 
activity with all yeasts at lower concentrations. Any 
considerable antimicrobial activities were not observed 
 for compound 2, 4, 5 and 6 at the highest concentration  
(4,0 mg L–1). As an interesting outcome, the compound 1 
exhibited better MIC values at a wide range of concentration 
(1–4 mg L–1) despite its simplicity. 
 In summary, six different water soluble NHC salts 
were synthesized in high yields and structurally analyzed. 
Also, their antimicrobial activities were examined. All 
synthesized compounds showed antimicrobial activities 
while the compound 1 is still the best among the others. 
We believe that this result might safely be attached to the 
fact that the compound 1 is the smallest one. The smaller 
molecules can penetrate into the cell through the 
membrane and damage the organelles. As a matter of fact, 
our results can be looked down according to MIC values. 
However, it should be considered that an antimicrobial is 
not only used as medicine but also, it is quite useful for daily 
use such as surface disinfection and in agricultural 
practices. Also, these substances can be further 
investigated for drug delivery systems, and they will give 
synergetic profits in use. 
 
Table 2. MIC values (mg L–1) for ILs. 
Microorganism 
MIC / mg L–1 
Compounds 
Gentamicin Nystatin 
1 2 3 4 5 6 
Gram positive bacteria 
Staphylococcus aureus > 4.0 > 4.0 > 4.0 > 4.0 > 4.0 > 4.0 0.008 n.t.(a) 
Enterococcus faecium 2 > 4.0 > 4.0 > 4.0 > 4.0 > 4.0 0.008 n.t.(a) 
Bacillus subtilis 2 > 4.0 > 4.0 > 4.0 > 4.0 > 4.0 0.0005 n.t.(a) 
Gram negative bacteria 
Escherichia coli 4 > 4.0 > 4.0 > 4.0 > 4.0 > 4.0 0.001 n.t.(a) 
Salmonella typhimurium > 4.0 > 4.0 > 4.0 > 4.0 > 4.0 > 4.0 0.002 n.t.(a) 
Pseudomonas aeruginosa 4 > 4.0 2 > 4.0 > 4.0 > 4.0 0.0005 n.t.(a) 
Yeasts 
Candida albicans > 4.0 > 4.0 > 4.0 > 4.0 > 4.0 2 n.t.(a) 0.006 
Candida krusei 1 4 > 4.0 4 2 2 n.t.(a) 0.003 
Candida tropicalis 1 1 4 2 2 0.5 n.t.(a) 0.006 
(a) n.t. – not tested. 
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Appendix A. Supplementary Material.  
Supplementary data also can be found in the supplementary 
material file named “suppkunduracioglu2014.docx” and 
“suppkunduracioglu2014.pdf.” Also, NMR and FT-IR source 
files and pictures of spectra can be found in 
“suppkunduracioglu2014.rar” file too. 
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